United Therapeutics Corporation (UTHR) — Cash Flow Reinvestment Rate
United Therapeutics Corporation (UTHR) has a Cash Flow Reinvestment Rate of 0.63x as of September 2025, reinvesting $351.40 Million (capex $210.50 Million plus investments $140.90 Million) from operating cash flow of $562.10 Million. Explore United Therapeutics Corporation capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
United Therapeutics Corporation Cash Flow Reinvestment Rate (2004–2024)
Historical reinvestment intensity for United Therapeutics Corporation across 19 annual periods. Also explore United Therapeutics Corporation (UTHR) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for United Therapeutics Corporation (2004–2024)
Year-by-year capital reinvestment analysis for United Therapeutics Corporation. For live market cap and broader valuation context, see UTHR market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | $663.70 Million | $1.33 Billion | $246.50 Million | ▼ -58.6% |
| 2023 | 1.21x | $1.18 Billion | $978.00 Million | $230.40 Million | ▲ +17.9% |
| 2022 | 1.02x | $822.40 Million | $802.50 Million | $138.80 Million | ▲ +25.9% |
| 2021 | 0.81x | $486.90 Million | $598.20 Million | $120.80 Million | ▼ -17.0% |
| 2020 | 0.98x | $740.90 Million | $755.70 Million | $59.30 Million | ▲ +17.3% |
| 2018 | 0.84x | $650.50 Million | $778.40 Million | $184.40 Million | ▼ -53.0% |
| 2017 | 1.78x | $844.00 Million | $474.20 Million | $86.30 Million | ▲ +750.4% |
| 2016 | 0.21x | $134.70 Million | $643.60 Million | $43.20 Million | ▼ -68.4% |
| 2015 | 0.66x | $253.16 Million | $382.80 Million | $49.79 Million | ▼ -45.8% |
| 2014 | 1.22x | $433.34 Million | $355.30 Million | $47.44 Million | ▲ +75.8% |
| 2013 | 0.69x | $294.97 Million | $425.27 Million | $31.91 Million | ▲ +37.4% |
| 2012 | 0.50x | $163.36 Million | $323.63 Million | $111.91 Million | ▲ +7.2% |
| 2011 | 0.47x | $117.78 Million | $250.19 Million | $35.98 Million | ▼ -55.4% |
| 2010 | 1.05x | $223.14 Million | $211.53 Million | $18.64 Million | ▲ +10.3% |
| 2009 | 0.96x | $95.40 Million | $99.72 Million | $95.40 Million | ▲ +21.1% |
| 2007 | 0.79x | $38.66 Million | $48.95 Million | $38.66 Million | ▲ +149.5% |
| 2006 | 0.32x | $15.63 Million | $49.39 Million | $15.63 Million | ▲ +123.4% |
| 2005 | 0.14x | $6.12 Million | $43.17 Million | $6.12 Million | ▼ -43.6% |
| 2004 | 0.25x | $5.22 Million | $20.78 Million | $5.22 Million | — |